Home Cart Sign in  
Chemical Structure| 2220184-50-7 Chemical Structure| 2220184-50-7

Structure of CDK12-IN-3
CAS No.: 2220184-50-7

Chemical Structure| 2220184-50-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CMPD 7 is a potent and selective CDK12 inhibitor with an IC50 of 491 nM in enzymatic assay.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CDK12-IN-3

CAS No. :2220184-50-7
Formula : C23H28F2N8O
M.W : 470.52
SMILES Code : CC(C)N(C=N1)C2=C1C(NCC3=NC(C(F)=C(F)C=C4)=C4N3)=NC(N5CCCC[C@H]5CCO)=N2
MDL No. :N/A

Safety of CDK12-IN-3

Related Pathways of CDK12-IN-3

Hedgehog

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01951885 Chronic Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Biphenotypic Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Hodgkins Disease Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 3 Recruiting July 2019 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Withdrawn Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Betty Hamilton, MD    216-444-2529    hamiltb2@ccf.org    Principal Investigator: Betty Hamilton, MD Less <<
NCT00101296 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Erythroid Leukemia (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00710892 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Myelodysplastic Syndrome Chronic Myeloid Leukemia Less << Phase 1 Active, not recruiting July 2026 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01650467 - Withdrawn(Funding is late, unf... More >>orseeable.) Less << June 2017 France ... More >> Clinique du Parc Castelnau Le Lez, France, 34170 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 Less <<
NCT00719563 Chronic Myeloproliferative Dis... More >>orders Fatigue Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT00816413 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Nonmalignant Neoplasm Less << Phase 1 Phase 2 Withdrawn(Screenings yielded i... More >>nadequate eligible subjects to enroll.) Less << - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT02530619 Acute Megakaryoblastic Leukemi... More >>a Myelofibrosis Primary Myelofibrosis Less << Not Applicable Active, not recruiting March 2020 United States, Florida ... More >> University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01340651 Myelofibrosis Phase 2 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States United States, Florida Winter Park, Florida, United States United States, Texas Houston, Texas, United States, TX Less <<
NCT01801046 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myeloid Leukemia in Remission Childhood Acute Myelomonocytic Leukemia (M4) Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 1 Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00362466 Leukemia Phase 3 Terminated(Insufficient Enroll... More >>ment) Less << - -
NCT00531310 Chronic Myeloid Leukemia Phase 2 Terminated(Poor accrual) - United States, New York ... More >> Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 Less <<
NCT01340651 - Completed - -
NCT00362466 - Terminated(Insufficient Enroll... More >>ment) Less << - -
NCT00719563 - Completed - -
NCT00975975 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplasia Non-Hodgkin's Lymphoma Hodgkin's Disease Multiple Myeloma Myelofibrosis Anemia, Aplastic Hemoglobinuria, Paroxysmal Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT02543749 Myeloid Leukemia, Chronic Phase 1 Phase 2 Recruiting January 2019 Germany ... More >> Charité - University Medicine Berlin Recruiting Berlin, Germany, 13353 Contact: Jörg Westermann, Prof. Dr.    +49-30-450-553141    joerg.westermann@charite.de    Klinikum Bremen Mitte Not yet recruiting Bremen, Germany, 28177 Contact: Bernd Hertenstein, Prof. Dr. Less <<
NCT00975975 - Completed - -
NCT01218477 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> University Of California Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Texas Ut M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8N 3Z5 Local Institution Toronto, Ontario, Canada, M5G 2M9 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Bordeaux, France, 33076 Local Institution Poitiers Cedex, France, 86021 Germany Local Institution Frankfurt/main, Germany, 60590 Italy Local Institution Bologna, Italy, 40138 Local Institution Orbassano(To), Italy, 10043 United Kingdom Local Institution Glasgow, United Kingdom, G12 0YN Less <<
NCT00634244 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio The Jewish Hospital Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-2001 Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania, United States, 18201 Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Lewistown Hospital Lewistown, Pennsylvania, United States, 17044 Geisinger Medical Group State College, Pennsylvania, United States, 16801 Mount Nittany Medical Center State College, Pennsylvania, United States, 16803 Geisinger Wyoming Valley Wilkes-Barre, Pennsylvania, United States, 18711 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Less <<
NCT03326310 Chronic Myeloid Leukemia ... More >> Myelofibroses Less << Phase 1 Recruiting September 4, 2023 United States, Illinois ... More >> The University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Melissa Fridstein    773-702-9885    mfridstein@medicine.bsd.uchicago.edu Less <<
NCT00003190 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT01218477 - Completed - -
NCT00895934 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Washington Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton, Washington, United States, 98310 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 Less <<
NCT00462605 - Completed - -
NCT01413568 Acute Myeloid Leukemia in Remi... More >>ssion Adult Acute Lymphoblastic Leukemia in Remission Chronic Myelogenous Leukemia (CML) Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission Chronic Lymphocytic Leukemia (CLL) Multiple Myeloma (MM) Myelodysplastic Syndrome (MDS) Myeloproliferative Disorders Less << Phase 1 Phase 2 Completed - United States, Kansas ... More >> University of Kansas Cancer Center Kansas City, Kansas, United States, 66205 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00634244 - Completed - -
NCT01555268 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Rochester, New York, United States, 14642 Less <<
NCT02767063 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 1 Phase 2 Recruiting June 2021 France ... More >> Martine GARDEMBAS Recruiting Angers, France Contact: Martine GARDEMBAS    02.41.35.44.75    MaGardembas@chu-angers.fr    Pascale CONY.MAKHOUL Recruiting Annecy, France Contact: Pascale CONY.MAKHOUL    04.50.63.64.31    pconymakhoul@ch-annecygenevois.fr    Thorsten BRAUN Recruiting Bobigny, France Contact: Thorsten BRAUN    01.48.95.54.58    Thorsten.braun@avc.aphp.fr    Etienne Recruiting Bordeaux, France Contact: Gabriel Etienne    05.56.33.04.76    G.Etienne@bordeaux.unicancer.fr    CHU Côte de Nacre Not yet recruiting Caen, France Contact: Hyacynthe Johnson-Ansah    02.31.27.25.39    Johnsonansah-a@chu-caen.fr    CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Marc BERGER       mberger@chu-clermontferrand.fr    CH Henri Mondor Recruiting Créteil, France Contact: ROY Lydia          Rousselot Recruiting Le Chesnay, France Contact: Philippe Rousselot    01.39.63.89.09    phrousselot@ch-versailles.fr    CHU Lille Recruiting Lille, France Contact: COITEUX Valérie          CHU de LIMOGES Not yet recruiting Limoges, France Contact: Amélie PENOT    05.55.05.66.42    Amelie.penot@chu-limoges.fr    Franck NICOLINI Recruiting Lyon, France Contact: Franck NICOLINI    04.72.11.74.01    franck.nicolini@chu-lyon.fr    Institut P Calmette Recruiting Marseille, France Contact: CHARBONNIER Aude          Viviane DUBRUILLE Recruiting Nantes, France Contact: Viviane DUBRUILLE    02.40.08.32.71    Viviane.dubruille@chu-nantes.fr    Hopital l'Archet Not yet recruiting Nice, France Contact: Laurence LEGROS    04.92.03.58.41    legros.l@chu-nice.fr    Eric JOURDAN Recruiting Nimes, France Contact: Eric JOURDAN    04.66.68.32.31    eric.jourdan@chu-nimes.fr    Hôpital La Source Recruiting Orléans, France Contact: BENBRAHIM Omar          Delphine REA _St louis Recruiting Paris, France Contact: Delphine REA    01.42.49.96.49    delphine.rea@aphp.fr    Simona LAPUSAN_St Antoine Recruiting Paris, France Contact: Simona LAPUSAN    01.49.28.34.42    Simona.lapusan@sat.aphp.fr    Cayssials Recruiting Poitiers, France Contact: Emilie Cayssials    : 05.49.44. 44.72    e.cayssials@chu-poitiers.fr    CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: ESCOFFRE-BARBE Martine          Hôpital René Huguenin Not yet recruiting Saint-Cloud, France Contact: Sylvie GLAISNER    01.47.11.15.30    Sylvie.glaisner@curie.net    Institut Universitaire contre le Cancer Not yet recruiting Toulouse, France Contact: Françoise HUGUET    05.31.15.63.56    Huguet.françoise@iuct-oncopole.fr    CHU Tours Not yet recruiting Tours, France Contact: DARTIGEAS Caroline Less <<
NCT00462605 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT01872819 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01795677 Myelofibrosis Phase 2 Active, not recruiting March 2019 France ... More >> ROBIN Paris, France, 75010 Less <<
NCT01839240 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting September 2018 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT02734823 - Recruiting March 1, 2020 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Irene Woo    323-226-2850    Irene.woo@med.usc.edu    Principal Investigator: Irene Woo Less <<
NCT00895934 - Completed - -
NCT01031368 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00281879 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood Less << Phase 2 Terminated - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00281879 - Terminated - -
NCT01904643 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Accrual factor) - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT01872819 - Completed - -
NCT02885766 Chronic Myeloid Leukemia ... More >> Leukemia, Myelogenous, Chronic, BCR-ABL Positive Less << Phase 1 Phase 2 Recruiting October 2018 Russian Federation ... More >> Federal Haematological Scientific Center Recruiting Moscow, Russian Federation, 125167 Contact: Anna Turkina, Professor    7 495 612 44 72    turkianna@yandex.ru    Contact: Oleg Shukhov, PhD    +7 985 287 12 69    shuhov@list.ru    Moscow City Centre of Hematology based on City Hospital named by S.Botkin Recruiting Moscow, Russian Federation, 125284 Contact: Olga Vinogradova, Prof. DMSci    +7(495)945-97-61    olgavinz@mail.ru    Federal Almazov North-West Medical Research Centre Recruiting St. Petersburg, Russian Federation Contact: Elza Lomaia, MD, PhD    +7 981 936 16 67    lomelza@gmail.com Less <<
NCT02144675 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01820624 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT02144675 - Completed - -
NCT00006379 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00109993 Breast Cancer ... More >> Chronic Myeloproliferative Disorders Gestational Trophoblastic Tumor Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Neuroblastoma Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Ohio Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-7284 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Texas Transplant Institute San Antonio, Texas, United States, 78229 Less <<
NCT01093586 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Blastic Phase Chronic Myelogenous Leukemia Burkitt Lymphoma Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Splenic Marginal Zone Lymphoma Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Waldenstrom Macroglobulinemia Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT02527174 Leukemia, Myeloid, Acute ... More >> Leukemia, Monocytic, Acute Leukemia, Myelomonocytic, Acute Leukemia, Erythroblastic, Acute Leukemia, Megakaryoblastic, Acute Less << Phase 1 Withdrawn(Volasertib no longer... More >> available) Less << September 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 University of Alberta Hospital Edmonton, Alberta, Canada, T6G 2G3 Less <<
NCT00375219 - Completed - -
NCT00666211 Brain and Central Nervous Syst... More >>em Tumors Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Pain Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - United States, Kentucky ... More >> Jennie Stuart Medical Center Hopkinsville, Kentucky, United States, 44240 Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States, 42303 United States, Tennessee Erlanger Health System Chattanooga, Tennessee, United States, 37403 Tennessee Plateau Oncology Crossville, Tennessee, United States, 38555 Center for Biomedical Research Knoxville, Tennessee, United States, 37909 The Jones Clinic Memphis, Tennessee, United States, 38138 Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Meharry Medical College Nashville, Tennessee, United States, 37208 Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00462943 - Completed - -
NCT00666211 - Completed - -
NCT00074490 Lymphoma Leuk... More >>emia Myeloproliferative Disorders Multiple Myleoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States Less <<
NCT00462943 Chronic Myeloid Leukemia Phase 2 Completed - -
NCT02521493 Blasts 5 Percent or More of Bo... More >>ne Marrow Nucleated Cells Childhood Acute Myeloid Leukemia Childhood Myelodysplastic Syndrome Cytopenia Down Syndrome Myeloid Leukemia Associated With Down Syndrome Myeloproliferative Neoplasm Trisomy 21 Trisomy 21 Mosaicism Less << Phase 3 Recruiting - -
NCT00375219 Chronic Myeloid Leukemia Phase 2 Completed - -
NCT02598297 Early Myelofibrosis With High ... More >>Molecular Risk Mutations Less << Phase 3 Completed - -
NCT00726232 MPN (Myeloproliferative Neopla... More >>sms) Less << Phase 2 Completed - United States, Texas ... More >> Houston, Texas, United States, 77030 Italy Bergamo, Italy Firenze, Italy Pavia, Italy Less <<
NCT01349972 - Completed - -
NCT00054236 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01349972 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States, 85259 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT03622788 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Aplastic Anemia Bone Marrow Failure Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Follicular Lymphoma Hematopoietic Cell Transplantation Recipient Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Near Complete Response of Multiple Myeloma or Plasma Cell Leukemia Non-Hodgkin Lymphoma Partial Response of Multiple Myeloma or Plasma Cell Leukemia Plasma Cell Myeloma Less << Phase 1 Phase 2 Not yet recruiting April 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Richard E. Champlin    713-792-8750       Principal Investigator: Richard E. Champlin Less <<
NCT02523638 Polycythemia Vera Phase 3 Completed - -
NCT03662126 Primary Myelofibrosis (PMF) ... More >> Post-Polycythemia Vera MF (Post-PV-MF) Post-Essential Thrombocythemia MF (Post-ET-MF) Less << Phase 2 Recruiting February 28, 2023 United States, California ... More >> Innovative Clinical Research Institute Recruiting Whittier, California, United States, 90603 Contact: Kirsten Bettino    562-693-4477    kbettino@airesearch.us    United States, Florida University Cancer Institute Recruiting Boynton Beach, Florida, United States, 33426 Contact: Paula Ortiz    561-737-6556    portiz@universitycancerinstitute.com    United States, Minnesota Health Partners Institute Recruiting Saint Paul, Minnesota, United States, 55101 Contact: Jennifer Collier    651-254-3391    jennifer.collier@parknicollet.com    United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Karyn Gordon    314-362-9236    kdgordon@wustl.edu    United States, New Jersey Summit Medical Group Recruiting Florham Park, New Jersey, United States, 07932 United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Carrie Smith    330-492-3345 ext 208    csmith@gabrailcancercenter.com Less <<
NCT02515630 Primary Myelofibrosis (PMF) ... More >> Post-polycythemia Vera (Post-PV) Myelofibrosis Postessential Thrombocythemia (Post-ET) Myelofibrosis Less << Phase 2 Completed - United States, Arizona ... More >> Phoenix, Arizona, United States United States, California Los Angeles, California, United States Orange, California, United States United States, Florida Jacksonville, Florida, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Ann Arbor, Michigan, United States United States, Missouri Saint Louis, Missouri, United States United States, New York Bronx, New York, United States New York, New York, United States United States, North Carolina Durham, North Carolina, United States United States, Ohio Cleveland, Ohio, United States United States, Texas Houston, Texas, United States Canada, Ontario Toronto, Ontario, Canada Less <<
NCT02129101 Chronic Myelomonocytic Leukemi... More >>a de Novo Myelodysplastic Syndrome Essential Thrombocythemia Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Polycythemia Vera Previously Treated Myelodysplastic Syndrome Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting October 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01904136 Leukemia Myel... More >>oproliferative Diseases Less << Phase 1 Phase 2 Recruiting April 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00006348 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nausea and Vomiting Precancerous Condition Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 3 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00726232 - Completed - -
NCT02016833 - Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Center Melbourne, Victoria, Australia, 3002 Less <<
NCT01300611 Double Cord Blood Transplant ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Myelofibrosis Acute Lymphoblastic Leukemia Chronic Myelocytic Leukemia Non Hodgkins Lymphoma Hodgkins Lymphoma Chronic Lymphocytic Leukemia Less << Phase 1 Active, not recruiting September 2020 United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00005823 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT03314974 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma Chronic Myelogenous Leukemia Plasma Cell Leukemia Myeloproliferative Neoplasms Myelofibrosis Myelodysplasia Refractory Anemia High Risk Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large Cell Non Hodgkins Lymphoma Lymphoblastic Lymphoma Burkitt Lymphoma High Grade Non-Hodgkin's Lymphoma, Adult Multiple Myeloma Juvenile Myelomonocytic Leukemia Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Natural Killer Cell Malignancies Acquired Bone Marrow Failure Syndromes Less << Phase 2 Recruiting November 10, 2023 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55337 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@Fairview.org Less <<
NCT01831232 - Completed - -
NCT00538850 - Completed - -
NCT02871323 Polycythemia Vera, Post-Polycy... More >>themic Myelofibrosis Phase Primary Myelofibrosis Less << Phase 1 Active, not recruiting July 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00569660 Myelofibrosis Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03117816 Chronic Myeloid Leukemia in Re... More >>mission Less << Phase 2 Recruiting December 2024 Germany ... More >> Universitätsklinikum Aachen Recruiting Aachen, Germany, 52074 Contact: Martina Crysant, MD    ++49 241 80 ext 80591    mcrysandt@ukaachen.de    Contact: Tim H. Brümmendorf, Prof    ++49 241 80 ext 89805    tbruemmendorf@ukaachen.de    Principal Investigator: Martina Crysant, MD          Studienzentrum Aschaffenburg Recruiting Aschaffenburg, Germany, 63739 Contact: Martine Klausmann, MD    ++49 6021-342 ext 780    mk@klausmann.de    Contact: Silke Schirrmacher-Memmel, MD    ++49 6021-342 ext 780    sm@klausmann.de    Universitätsmedizin Berlin Charite- Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Philipp Le Courte, MD    ++49 30 450 665 ext 307    philipp.lecoutre@charite.de    Contact: Theo Kim, MD    ++49 30 450 ext 513077    theo.kim@charite.de    Principal Investigator: Philipp Le Courte, MD          Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III Recruiting Bonn, Germany, 53105 Contact: Jai-Jün Shiue, MD    ++49 228 287 17 ext 233    jai-juen.shiue@ukb.uni-bonn.de    Contact: Lino Teichmann, MD    0228-287 51 ext 630    lino.teichmann@ukb.uni-bonn.de    Klinikum Bremen Mitte, Medizinische Klinik I Recruiting Bremen, Germany, 28177 Contact: Matthias Bormann, Dr.med.    ++49 421 497 ext 5132    matthias.bormann@klinikum-bremen-mitte.de    Contact: Bernd Hertenstein, Prof    ++49 421 497 ext 5240    bernd.hertenstein@klinikum-bremen-mitte.de    BAG / Onkologische Gemeinschaftspraxis Recruiting Dresden, Germany, 01307 Contact: Thomas Illmer, PD Dr.    ++49 351 44000 ext 22    illmer@onkologie-dresden.net    Contact: Jens Freiberg-Richter, Dr. med.    ++49 351 44000 ext 22    freiberg-richter@onkologie-dresden.net    Universitätsklinikum Düsseldorf Recruiting Dusseldorf, Germany, 40225 Contact: Norbert Gattermann, Prof    +49 211- 81 ext 16500    gattermann@med.uni-duesseldorf.de    Contact: Judith Strapatsas (née Neukirchen), MD    +49 211- 81 ext 17720    judith.strapatsas@med.uni-duesseldorf.de    Principal Investigator: Norbert Gattermann, Prof          Universitätsklinikum Erlangen Recruiting Erlangen, Germany, 91054 Contact: Stefan Krause, Prof    ++49 9131 85 ext 35957    stefan.krause@uk-erlangen.de    Contact: Norbert Meidenbauer, PD, MD    ++49 9131 85 ext 36766    norbert.meidenbauer@uk-erlangen.de    Principal Investigator: Stefan Krause, Prof          Universitätsklinikum Essen, Klinik für Hämatologie Recruiting Essen, Germany, 45147 Contact: Joachim Goethert, MD    ++49 201 723 84 ext 729    joachim.goethert@uk-essen.de    Contact: Maher Hanoun, MD    0201 723 83 ext 847    maher.hanoun@uk-essen.de    Klinikum der Goethe Universität, Medizinische Klinik II Recruiting Frankfurt a. Main, Germany, 60590 Contact: Fabian Lang, Dr.med.    ++49 69 6301 ext 4013    fabian.lang@kgu.de    Contact: Jörg Chromik, Dr.med.    ++49 69 6301 ext 6103    joerg.chromik@kgu.de    Universitätsklinikum Hamburg Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Philippe Schafhausen, Dr. med.    +49 40 7410 ext 57122    schafhausen@uke.de    Contact: Snjezana Janjetovic, Dr. med.    +49 40 7410 ext 50661    s.janjetovic@uke.de    Evangelische Krankenhaus Hamm gGmbH Recruiting Hamm, Germany, 59063 Contact: Elisabeth Lange, MD    0049 2381 90583 ext 25    marianne.david@valeo-kliniken.de    Contact: Thomas Wehler, Prof. Dr.    0049 2381 589 ext 1863    onkologie.hamm@valeo-kliniken.de    Onkologische Praxis Heilbronn Withdrawn Heilbronn, Germany, 74072 Universitätsklinikum Jena Recruiting Jena, Germany, 07740 Contact: Andreas Hochhaus, Prof    +49 3641 932 ext 4200    Andreas.Hochhaus@med.uni-jena.de    Contact: Thomas Schenk, MD    +49 3641 939 ext 6661    thomas.schenk@med.uni-jena.de    Principal Investigator: Andreas Hochhaus, Prof          Universitätsklinikum Leipzig Recruiting Leipzig, Germany, 04103 Contact: Georg-Nikolaus Franke, MD    ++49 341 97 ext 13020    Georg-Nikolaus.Franke@medizin.uni-leipzig.de    Contact: Song-Yau Wang, MD    ++49 341 97 ext 13030    song-yau.wang@medizin.uni-leipzig.de    Principal Investigator: Georg-Nikolaus Franke, MD          Johannes-Gutenberg-Universität III. Medizinische Klinik Recruiting Mainz, Germany, 55131 Contact: Thomas Kindler, PD, MD    ++49 6131 17 ext 5046    thomas.kindler@unimedizin-mainz.de    Contact: Markus Radsak, Prof    ++49 6131 17 ext 5947    radsak@uni-mainz.de    Principal Investigator: Thomas Kindler, PD, MD          Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68169 Contact: Susanne Saussele, PD, MD    ++49 621-383 ext 6966    Susanne.Saussele@medma.uni-heidelberg.de    Contact: Henning Popp, MD    ++49 621-383 ext 4115    henning.popp@medma.uni-heidelberg.de    Principal Investigator: Susanne Saussele, PD, MD          Universitätsklinikum Gießen und Marburg GmbH Recruiting Marburg, Germany, 35043 Contact: Andreas Burchert, Prof.    +49 6421 586 ext 6511    burchert@staff.uni-marburg.de    Contact: Stephan K. Metzelder, MD    +49 6421 586 ext 2724    metzelde@med.uni-marburg.de    Principal Investigator: Andreas Burchert, Prof.          Universitätsklinikum Münster Recruiting Muenster, Germany, 48149 Contact: Eva Esseling, MD    ++49 251 83 ext 52807    eva.esseling@ukmuenster.de    Contact: Jan-Henrik Mikesch, MD    ++49 251 83 ext 52818    Jan-Henrik.Mikesch@ukmuenster.de    Principal Investigator: Eva Schmidt, MD          III. Medizinischen Klinik TUM Klinikum rechts der Isar Recruiting Munich, Germany, 81675 Contact: Philipp Jost, PD, MD    ++49 89 4140 ext 5941    philipp.jost@tum.de    Contact: Stefanie Jilg, MD    ++49 89 4140 ext 4111    stefanie.jilg@tum.de    Principal Investigator: Philipp Jost, PD, MD          Universitätsklinikum Tübingen Recruiting Tubingen, Germany, 72076 Contact: Robert Möhle, Prof    ++40 7071-29 ext 83179    robert.moehle@med.uni-tuebingen.de    Contact: Martin Sökler, MD    ++40 7071-29 ext 80686    martin.soekler@med.uni-tuebingen.de    Principal Investigator: Robert Möhle, Prof          Universitätsklinikum Ulm Recruiting Ulm, Germany, 89081 Contact: Frank Stegelmann, MD    ++49 731-500 ext 45521    frank.stegelmann@uniklinik-ulm.de    Contact: Konstanze Döhner, Prof    ++49 731-500 ext 45505    konstanze.doehner@uniklinik-ulm.de    Principal Investigator: Frank Stegelmann, MD          Universitätsklinikum Würzburg, Zentrum für Innere Medizin Recruiting Würzburg, Germany, 97080 Contact: Maria-Elisabeth Goebeler, Dr.med.    ++49 931 201 ext 40966    goebeler_m@ukw.de    Contact: Volker Kunzmann, Prof. Dr. med.    ++49 931 201 ext 40004    kunzmann_v@ukw.de Less <<
NCT00569660 - Completed - -
NCT01233921 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blastic Phase Chronic Myelogenous Leukemia Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01831232 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Refractory Anemia With Excess Blasts Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01518153 - Terminated(Objectives not met.... More >>) Less << - -
NCT00538850 Cancer Phase 3 Completed - United States, Arizona ... More >> InSys Therapeutics, Incorporated Chandler, Arizona, United States, 85224 Less <<
NCT00513474 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 Less <<
NCT00005863 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Less <<
NCT00513474 - Completed - -
NCT01375140 Myeloproliferative Diseases Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01233921 - Completed - -
NCT01444742 - Completed - -
NCT00499668 Myeloproliferative Disorders ... More >> Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nausea and Vomiting Solid Tumor Less << Not Applicable Withdrawn(slow accrual) - -
NCT01118013 Leukemia Lymp... More >>homa Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Terminated - United States, Delaware ... More >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Florida Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States, 32803-1273 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT01518153 Leukemia Lymp... More >>homa Myeloma Myeloproliferative Diseases Less << Phase 2 Terminated(Objectives not met.... More >>) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01118013 - Terminated - -
NCT00014495 - Completed - -
NCT00014495 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01611298 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Hodgkin Lymphoma Non-Hodgkin Lymphoma Less << Not Applicable Completed - United States, Texas ... More >> Texas Childen's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01269593 Non-Hodgkin's Lymphoma ... More >> Myeloma Active Solid Malignancy Less << Early Phase 1 Recruiting December 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Mark Dunphy, DO    212-639-8131       Contact: Gabriela Chiosis, PhD    646-888-2235       Principal Investigator: Mark Dunphy, DO Less <<
NCT00539695 Acute Lymphoblastic Leukemia ... More >> ALL Acute Myelogenous Leukemia AML Chronic Myelogenous Leukemia Myelodysplastic Syndrome Myeloproliferative Disorder Hodgkin Lymphoma Non-Hodgkin Lymphoma Non-malignant Diseases Requiring Allogeneic HSCT Less << Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00539695 - Completed - -
NCT00114257 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT01444742 Leukemia Myel... More >>oproliferative Diseases Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01101880 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Untreated Adult Acute Myeloid Leukemia Myeloproliferative Neoplasm With 10% Blasts or Higher Less << Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Stanford, California, United States, 94305 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01101880 - Completed - -
NCT00068523 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Not Applicable Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT03149055 Hematologic Malignancy ... More >> Myeloproliferative Disorder Less << Phase 2 Active, not recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00530218 - Completed - -
NCT01394640 - Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy, 20133 Less <<
NCT00293410 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01950585 Pulmonary Hypertension Early Phase 1 Withdrawn - -
NCT02084563 Acute Myeloid Leukemia ... More >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm Less << Phase 2 Completed - Brazil ... More >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 Less <<
NCT00530218 Myelodysplastic/Myeloprolifera... More >>tive Neoplasm, Unclassifiable Leukemia Lymphoma Multiple Myeloma MDS Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 Less <<
NCT00356928 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Terminated(Poor accrual) - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT03397173 Myelodysplastic Syndromes ... More >> Myeloproliferative Neoplasm Acute Myeloid Leukemia Less << Phase 2 Recruiting January 2020 United States, Ohio ... More >> Cleveland Clinic, Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Aziz Nazha, MD    216-445-0320    nazhaa@ccf.org    Principal Investigator: Aziz Nazha, MD Less <<
NCT00624936 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT03613532 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable) Hematopoietic Stem Cell Transplant Less << Phase 1 Recruiting February 1, 2021 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacqueline S Garcia, MD    617-632-1906    jacqueline_garcia@dfci.harvard.edu    Principal Investigator: Jacqueline S Garcia, MD Less <<
NCT00301938 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Myelodysplastic/Myeloproliferative Neoplasms Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia T-cell Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less <<
NCT03289910 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Polycythemia Vera Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Recruiting June 1, 2020 United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact    410-955-8804    jhcccro@jhmi.edu    Principal Investigator: Keith W. Pratz Less <<
NCT02121418 Chronic Myelomonocytic Leukemi... More >>a-2 Myelodysplastic Syndrome Myeloproliferative Neoplasm Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, Montana ... More >> Bozeman Deaconess Hospital Bozeman, Montana, United States, 59715 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 EvergreenHealth Medical Center Kirkland, Washington, United States, 98033 Skagit Valley Hospital Mount Vernon, Washington, United States, 98274 Olympic Medical Center Port Angeles, Washington, United States, 98362 Group Health Cooperative Redmond, Washington, United States, 98052 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Multicare Health System Tacoma, Washington, United States, 98415 Wenatchee Valley Hospital and Clinics Wenatchee, Washington, United States, 98801 Less <<
NCT00411281 Leukemia Phase 3 Withdrawn(Per Group Chair This... More >> study will not move forward.) Less << - -
NCT00588991 Adult Acute Megakaryoblastic L... More >>eukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Essential Thrombocythemia Hematopoietic and Lymphoid Cell Neoplasm Myelodysplastic Syndrome Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Polycythemia Vera Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02564536 Chronic Myelomonocytic Leukemi... More >>a Juvenile Myelomonocytic Leukemia Atypical Chronic Myeloid Leukemia Myeloproliferative Neoplasm Myelodysplastic Syndromes Myelofibrosis Less << Phase 1 Withdrawn(Lack of funding foll... More >>owing full FDA clinical hold) Less << June 30, 2020 -
NCT02268253 Myelofibrosis ... More >> Chronic Myelomonocytic Leukemia Less << Phase 1 Phase 2 Recruiting June 2019 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Haris Ali, M.D.    626-256-4673 ext 62684    harisali@coh.org    Principal Investigator: Haris Ali, M.D.          University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Gary Schiller, MD    310-825-5513    gschiller@mednet.ucla.edu    Principal Investigator: Gary Schiller, M.D.          United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Contact: Abdulraheem Yacoub, M.D.    913-588-6029    ayacoub@kumcc.edu    Principal Investigator: Abdulraheem Yacoub, M.D.          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Moshe Talpaz, MD       mtalpaz@med.umich.edu    Principal Investigator: Moshe Talpaz, M.D.          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mrinal Patnaik, M.B.B.S..       patnaik.mrinal@mayo.edu    Principal Investigator: Mrinal Patnaik, M.B.B.S.          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: James McCloskey, M.D.       jmccloskey@hackensackumc.org    Principal Investigator: James McCloskey, M.D.          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD    716-845-3544    eunice.wang@roswellpark.org    Principal Investigator: Eunice Wang, MD          Weill Cornell Medical Center Recruiting New York, New York, United States, 10021 Contact: Sangman Lee, M.D.       sal9053@med.cornell.edu    Principal Investigator: Sangman Lee, M.D.          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naveen Pemmaraju, M.D.    713-792-4956    npemmaraju@mdanderson.org    Principal Investigator: Naveen Pemmaraju, M.D.          Canada, Alberta University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2G3 Contact: Minakshi Taparia, MD    780-407-1584       Principal Investigator: Minakshi Taparia, M.D.          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Vikas Gupta, MD    416-946-4521    vikas.gupta@uhn.ca    Principal Investigator: Vikas Gupta, M.D. Less <<
NCT02121418 - Completed - -
NCT02076191 Myeloproliferative Neoplasms Phase 1 Phase 2 Active, not recruiting December 2018 United States, Missouri ... More >> Washington University of St. Louis Saint Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Taussig Cancer Center Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03558607 Secondary Acute Myelogenous Le... More >>ukemia Evolving From Myeloproliferative Disorder Less << Phase 1 Phase 2 Recruiting December 31, 2021 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 13620 Contact: Ryul Kim, Dr    +82 10 9412 6108    chrono0707@icloud.com    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Ryul Kim, MD    +82 10 9412 6108    chrono0707@icloud.com    Principal Investigator: Youngil Koh, MD          Sub-Investigator: Sung soo Yoon, MD, PhD          Sub-Investigator: In ho Kim, MD          Sub-Investigator: Ryul Kim, MD Less <<
NCT01511575 - Completed - -
NCT00003593 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - -
NCT00357305 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blastic Phase Chronic Myelogenous Leukemia Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia de Novo Myelodysplastic Syndromes Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00949364 Myeloproliferative Neoplasms Phase 2 Completed - Germany ... More >> Universitätsklinikum Aachen Aachen, Germany, 52074 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 Zentrum für Ambulante Hämatologie und Onkologie Bonn, Germany, 53119 BAG Freiberg-Richter, Jacobasch, Wolf, Illmer (Gemeinschaftspraxis) Dresden, Germany, 01307 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Klinikum der Johann Goethe-Universität Frankfurt Frankfurt, Germany, 60590 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Universitätsklinikum Hamburg Eppendorf Hamburg Eppendorf, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07740 Universitätsklinikum Magdeburg AöR Magdeburg, Germany, 39120 Universitätsmedizin Mannheim Mannheim, Germany, 68167 Johannes Wesling Klinikum Minden Minden, Germany, 32429 Stauferklinikum Schwäbisch Gmünd Mutlangen, Germany, 73557 Haematologisch-onkologische Praxis München, Germany, 80331 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT01297543 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Myelodysplasia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Moores UCSD Cancer Center La Jolla, California, United States, 92037 University of California San Francisco Medical Center San Francisco, California, United States, 94143 Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Illinois Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States, 60153 United States, Indiana Indiana Blood and Marrow Transplantation, LLC Beech Grove, Indiana, United States, 46107 United States, Massachusetts University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania The Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00027872 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Erythroid Leukemia (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Cellular Diagnosis, Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00096122 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00103272 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Terminated - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00940784 Polycythemia Vera Phase 2 Withdrawn(Could not get drug) - -
NCT00101231 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Less << Phase 1 Terminated - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00096122 - Completed - -
NCT00089388 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00131989 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT01076569 - Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91006-3776 Less <<
NCT00095797 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00098423 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00004896 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00045435 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - United States, Oregon ... More >> OHSU Cancer Institute Portland, Oregon, United States, 97210 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00352365 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - -
NCT00352365 - Completed - -
NCT00407966 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT00407966 - Completed - -
NCT00098826 Acute Undifferentiated Leukemi... More >>a Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT00425477 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00425477 - Completed - -
NCT01790295 Primary Myelofibrosis ... More >> Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis Less << Phase 2 Active, not recruiting February 2021 United States, Georgia ... More >> Emory Hospital Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University, Robert h. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27103 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada Princess Margaret Cancer Centre, University of Toronto Toronto, Canada, M5G 2M9 United Kingdom University of Oxford Oxford, United Kingdom, OX3 9DS Less <<
NCT03669965 Polycythemia Vera Phase 2 Recruiting October 2023 United States, California ... More >> Innovative Clinical Research Institute Recruiting Whittier, California, United States, 90603 Contact: Kirsten Bettino    562-693-4477    kbettino@airesearch.us    United States, Florida University Cancer Institute Recruiting Boynton Beach, Florida, United States, 33426 Contact: Paula Ortiz    561-737-6556    portiz@universitycancerinstitute.com    United States, New Jersey Summit Medical Group Recruiting Florham Park, New Jersey, United States, 07932 United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Carrie Smith    330-492-3345 ext 208    csmith@gabrailcancercenter.com Less <<
NCT01550185 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Sponsor wanted stud... More >>y rewritten) Less << - United States, Georgia ... More >> Emory University, Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00045435 - Active, not recruiting - -
NCT00470197 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Malignant Neoplasm Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00574873 Chronic Myeloid Leukemia Phase 3 Completed - -
NCT02071901 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting December 2018 United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02019069 Adult Acute Erythroid Leukemia... More >> (M6) Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 2 Recruiting December 2019 United States, California ... More >> Stanford University, School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Jack Taw    650-723-1269    jtaw@stanford.edu    Principal Investigator: Rondeep Brar, MD Less <<
NCT01146210 - Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91006-3776 Less <<
NCT01235572 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00574873 - Completed - -
NCT01159301 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Blastic Phase Chronic Myelogenous Leukemia Recurrent Adult Acute Myeloid Leukemia Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.63mL

2.13mL

1.06mL

21.25mL

4.25mL

2.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories